Marta Soler

Marta Soler

Auto-generated profile, based on publicly available information

Marta Soler

QBIS-CAT Research Group, Institut de Química Computacional i Catàlisi (IQCC) and Departament de Química, Universitat de Girona, Campus Montilivi, E-17071 Girona, Catalonia, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2014 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MSMarta Soler
Marta Soler
MGMarta González-Bártulos
Marta González-Bártulos
DCDavid Soriano Castell
David Soriano Castell
XRXavi Ribas
Xavi Ribas
MCMiquel Costas
Miquel Costas
Marta PlanasMarta Planas
Marta Planas
Antimicrobial peptides are an interesting source of non-cytotoxic drug delivery vectors. Herein, we report on the identification of a new cell-penetrating peptide (KKLFKKILKKL-NH2, BP16) from a set of antimicrobial peptides selected from a library of cecropin-melittin hybrids (CECMEL11) previously designed to be used in plant protection. This set of peptides was screened for their cytotoxicity against breast adenocarcinoma MCF-7, pancreas adenocarcinoma CAPAN-1 and mouse embryonic fibroblast 3T3 cell lines. BP16 resulted to be non-toxic against both malignant and non-malignant cells at concentrations up to 200 μM. We demonstrated by flow cytometry and confocal microscopy that BP16 is mainly internalized in the cells through a clathrin dependent endocytosis and that it efficiently accumulates in the cell cytoplasm. We confirmed that the cell-penetrating properties of BP16 are retained after conjugating it to the breast tumor homing peptide CREKA. Furthermore, we assessed the potential of BP16 as a drug delivery vector by conjugating the anticancer drug chlorambucil to BP16 and to a CREKA-BP16 conjugate. The efficacy of the drug increased between 6 and 9 times when conjugated to BP16 and between 2 and 4.5 times when attached to the CREKA-BP16 derivative. The low toxicity and the excellent cell-penetrating properties clearly suggest that BP16 is a suitable vector for the delivery of therapeutic agents into cells.

1 February 2014 in Protein & Peptide Letters
Verified
Journal Article
Closed access
PDF file
INIteng Ng-Choi
Iteng Ng-Choi
MSMarta Soler
Marta Soler
IGImma Güell
Imma Güell
esther badosaesther badosa
esther badosa
JCJordi Cabrefiga
Jordi Cabrefiga
Lidia FeliuLidia Feliu
Lidia Feliu
The control of plant pathogens is mainly based on copper compounds and antibiotics. However, the use of these compounds has some limitations. They have a high environmental impact and the use of antibiotics is not allowed in several countries. Moreover, resistance has been developed to these pathogens. The identification of new agents able to fight plant pathogenic bacteria and fungi will represent an alternative to currently used antibiotics or pesticides. Antimicrobial peptides are widely recognized as promising candidates, however naturally occurring sequences present drawbacks that limit their development. These include susceptibility to protease degradation and low bioavailability. To overcome these problems, research has focused on the introduction of unnatural amino acids into lead peptide sequences. In particular, we have improved the biological profile of antimicrobial peptides active against plant pathogenic bacteria and fungi by incorporating triazolyl, biaryl and D-amino acids into their sequence. These modifications and their influence on the biological activity are summarized.

27 October 2015 in Inorganic Chemistry
Verified
Journal Article
Closed access
MSMarta Soler
Marta Soler
EFEduard Figueras
Eduard Figueras
JSJoan Serrano-Plana
Joan Serrano-Plana
MGMarta González-Bártulos
Marta González-Bártulos
AMAnna Massaguer
Anna Massaguer
MCMiquel Costas
Miquel Costas

25 June 2012 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
INIteng Ng‐Choi
Iteng Ng‐Choi
MSMarta Soler
Marta Soler
VCVanessa Cerezo
Vanessa Cerezo
esther badosaesther badosa
esther badosa
EMEmilio Montesinos
Emilio Montesinos
Lidia FeliuLidia Feliu
Lidia Feliu

26 November 2014 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MSMarta Soler
Marta Soler
MGMarta González-Bártulos
Marta González-Bártulos
EFEduard Figueras
Eduard Figueras
XRXavi Ribas
Xavi Ribas
MCMiquel Costas
Miquel Costas
Lidia FeliuLidia Feliu
Lidia Feliu
The undecapeptide KKLFKKILKKL-NH2 (BP16) is a non-toxic cell-penetrating peptide (CPP) that is mainly internalized into cancer cells through a clathrin dependent endocytic mechanism and localizes in late endosomes. Moreover, this CPP is able to enhance the cellular uptake of chlorambucil (CLB) improving its cytotoxicity. In this work, we further explored the cell-penetrating properties of BP16 and those of its arginine analogue BP308. We investigated the influence on the cytotoxicity and on the cellular uptake of conjugating CLB at the N- or the C-terminal end of these undecapeptides. The effect of incorporating the cathepsin B-cleavable sequence Gly-Phe-Leu-Gly in CLB-BP16 and CLB-BP308 conjugates was also evaluated. The activity of CLB was significantly improved when conjugated at the N- or the C-terminus of BP16, or at the N-terminus of BP308. While CLB alone was not active (IC50 of 73.7 to >100 μM), the resulting conjugates displayed cytotoxic activity against CAPAN-1, MCF-7, PC-3, 1BR3G and SKMEL-28 cell lines with IC50 values ranging from 8.7 to 25.5 μM. These results were consistent with the internalization properties observed for the corresponding 5(6)-carboxyfluorescein-labeled conjugates. The presence of the tetrapeptide Gly-Phe-Leu-Gly at either the N- or the C-terminus of CLB-BP16 conjugates further increased the efficacy of CLB (IC50 of 3.6 to 16.2 μM), which could be attributed to its selective release in the lysosomal compartment. Enzymatic assays with cathepsin B showed the release of CLB-Gly-OH from these sequences within a short time. Therefore, the combination of BP16 with an enzymatic cleavable sequence can be used as a drug delivery system for the effective uptake and release of drugs in cancer cells.